Tiziana Life Sciences (TLSA) Retained Earnings (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Retained Earnings of $118.7 million for Q4 2025, little changed year-over-year from $118.7 million in Q4 2024, and little changed quarter-over-quarter from $118.7 million in Q2 2025.
Tiziana Life Sciences (TLSA) Retained Earnings (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Retained Earnings history runs 9 years deep, the most recent figure standing at $118.7 million for Q4 2025.
- In Q4 2025, Retained Earnings changed 0.0% year-over-year to $118.7 million; the TTM figure through Dec 2025 stood at $118.7 million (changed 0.0% YoY), while the FY2025 annual figure was $118.7 million, changed 0.0% from the prior year.
- Retained Earnings for Q4 2025 stood at $118.7 million, roughly flat from $118.7 million in the prior quarter.
- The five-year high for Retained Earnings was $118.7 million in Q2 2024, with the low at $118.7 million in Q2 2021.
- The 5-year median for Retained Earnings is $118.7 million (2021), against an average of $118.7 million.
- The sharpest annual moves came in 2021 and 2022: Retained Earnings jumped 301.97% in 2021, then changed 0.0% in 2022.
- Tiziana Life Sciences' Retained Earnings stood at $118.7 million in 2021, then changed by 0.0% to $118.7 million in 2022, then changed by 0.0% to $118.7 million in 2023, then changed by 0.0% to $118.7 million in 2024, then changed by 0.0% to $118.7 million in 2025.
- Business Quant data shows TLSA's Retained Earnings at $118.7 million in Q4 2025, $118.7 million in Q2 2025, and $118.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 4.38 Bn |
| 10 | Tiziana Life Sciences | 132.48 Mn | 128.47 Mn | - | -163.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 118.70 Mn |
| Jun 30, 2025 | 118.70 Mn |
| Dec 31, 2024 | 118.70 Mn |
| Jun 30, 2024 | 118.70 Mn |
| Dec 31, 2023 | 118.70 Mn |
| Jun 30, 2023 | 118.70 Mn |
| Dec 31, 2022 | 118.70 Mn |
| Jun 30, 2022 | 118.70 Mn |
| Dec 31, 2021 | 118.70 Mn |
| Jun 30, 2021 | 118.70 Mn |
| Dec 31, 2020 | -82.28 Mn |
| Jun 30, 2020 | -58.77 Mn |
| Dec 31, 2019 | -55.47 Mn |
| Jun 30, 2019 | -50.76 Mn |
| Dec 31, 2018 | -46.12 Mn |
| Jun 30, 2018 | -45.90 Mn |
| Dec 31, 2017 | -39.50 Mn |